We’re Ready for ASCO GU 2026: Advancing Knowledge Together

We’re Ready for ASCO GU 2026: Advancing Knowledge Together

Vanessa Barue, Senior Medical Director, Medical Asset Lead, Global Medical Affairs Oncology

As the global GU oncology community prepares to gather in San Francisco for the American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU), colleagues from across Ipsen are energized by the opportunity to connect, learn, and contribute. ASCO GU is an important moment in the global medical congress calendar, bringing forward the latest developments in renal cell carcinoma (RCC) and the wider GU landscape.

RCC continues to represent a significant area of unmet need. The ASCO GU meeting convenes clinicians, researchers, medical leaders, and industry partners to exchange emerging evidence and scientific insights that can help shape the future of patient care. For Ipsen, it is an opportunity to reaffirm our commitment to improving outcomes for people living with GU cancers and to stay closely connected to new thinking and evolving trends across the field.

Scientific exchange remains central to progress. Throughout the meeting, our teams look forward to discussions on real‑world evidence, combination approaches, and the ongoing importance of patient‑centered innovation. These conversations drive forward the next wave of research, deepen understanding, and support best practice in GU oncology.

Partnership and collaboration underpin everything we do. ASCO GU offers a unique forum to strengthen relationships with clinicians, investigators, academic partners, advocacy groups, and peers across the oncology ecosystem. It is a valuable moment to listen, learn, and explore how shared ambition can translate into meaningful impact for patients.

We welcome questions about who we are, our science, and the value we aim to bring to the global oncology community.

If you are attending ASCO GU 2026, we look forward to connecting in person. Let’s continue the dialogue, exchange perspectives, and work together to advance care for people living with GU cancers.


See you in San Francisco!

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

Related stories